サマリー

呼吸器系薬剤の世界市場 2022-2026 年
Technavioは呼吸器系薬剤市場を監視しており、2022-2026年の間に269億5000万ドルの成長が見込まれ、予測期間中にCAGR 5.96%で進行する見込みである。当レポートでは、呼吸器系薬剤市場の全体分析、市場規模と予測、動向、成長促進要因、課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新のトレンドとドライバー、市場全体の環境について最新の分析を提供しています。市場は、持続可能で安全な呼吸器系薬剤へのニーズ、呼吸器系疾患の発生率と有病率の増加、患者の意識の高まりによって牽引されています。
呼吸器系薬剤の市場分析には、タイプ別セグメントと地理的展望が含まれます。
Technavioの呼吸器系薬剤市場は、以下のようにセグメント化されています。
タイプ別
- 気管支喘息
- COPD
- アレルギー性鼻炎
- 嚢胞性線維症
- その他の呼吸器疾患
地域別構成比
- 北米
- 欧州
- アジア
- その他の地域 (ROW)
本調査では、今後数年間の呼吸器系薬剤市場の成長を促進する主な理由の1つとして、呼吸器系疾患管理の高コストが挙げられています。また、生物製剤やバイオシミラーの利用可能性、補完代替医薬品の高い使用率は、市場の大規模な需要につながるでしょう。
Technavioは、複数のソースからのデータを調査、合成、総括する方法で、主要パラメータの分析により、市場の詳細な姿を提示します。呼吸器系薬剤市場に関する当レポートの対象領域は以下の通りです。
- 呼吸器系薬剤の市場サイジング
- 呼吸器系薬剤の市場予測
- 呼吸器系薬剤市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って、本レポートでは、Abbott Laboratories、AbbVie Inc.、Aerogen Pharma Ltd.、AstraZeneca Plc.を含むいくつかの主要呼吸器系薬剤市場ベンダーについて詳細に分析を行っています。AstraZeneca Plc、Aurobindo Pharma Ltd.、Boehringer Ingelheim International GmbH、Celon Pharma SA、Cipla Ltd.、F. Hoffmann La Roche Ltd.、GlaxoSmithKline Plc、Glenmark Pharmaceuticals Ltd. Lab. Corp of America Holdings、Lupin Ltd. Medisol Lifescience Pvt. Ltd. 、Merck and Co.Ltd.、Novartis AG、住友製薬㈱、Teva Pharmaceutical Industries Ltd.など。Ltd.、Teva Pharmaceutical Industries Ltd.、Vertex Pharmaceuticals Inc.、Wellona Pharmaの7社です。また、呼吸器系薬剤の市場分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が戦略を立て、今後訪れるすべての成長機会を活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/respiratory-drugs-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ billion)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ billion)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Type
o 5.1 Market segments
o Exhibit 24: Chart on Type - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
o 5.2 Comparison by Type
o Exhibit 26: Chart on Comparison by Type
o Exhibit 27: Data Table on Comparison by Type
o 5.3 Asthma - Market size and forecast 2021-2026
o Exhibit 28: Chart on Asthma - Market size and forecast 2021-2026 ($ billion)
o Exhibit 29: Data Table on Asthma - Market size and forecast 2021-2026 ($ billion)
o Exhibit 30: Chart on Asthma - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Asthma - Year-over-year growth 2021-2026 (%)
o 5.4 COPD - Market size and forecast 2021-2026
o Exhibit 32: Chart on COPD - Market size and forecast 2021-2026 ($ billion)
o Exhibit 33: Data Table on COPD - Market size and forecast 2021-2026 ($ billion)
o Exhibit 34: Chart on COPD - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on COPD - Year-over-year growth 2021-2026 (%)
o 5.5 Allergic rhinitis - Market size and forecast 2021-2026
o Exhibit 36: Chart on Allergic rhinitis - Market size and forecast 2021-2026 ($ billion)
o Exhibit 37: Data Table on Allergic rhinitis - Market size and forecast 2021-2026 ($ billion)
o Exhibit 38: Chart on Allergic rhinitis - Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Allergic rhinitis - Year-over-year growth 2021-2026 (%)
o 5.6 Cystic fibrosis - Market size and forecast 2021-2026
o Exhibit 40: Chart on Cystic fibrosis - Market size and forecast 2021-2026 ($ billion)
o Exhibit 41: Data Table on Cystic fibrosis - Market size and forecast 2021-2026 ($ billion)
o Exhibit 42: Chart on Cystic fibrosis - Year-over-year growth 2021-2026 (%)
o Exhibit 43: Data Table on Cystic fibrosis - Year-over-year growth 2021-2026 (%)
o 5.7 Other respiratory diseases - Market size and forecast 2021-2026
o Exhibit 44: Chart on Other respiratory diseases - Market size and forecast 2021-2026 ($ billion)
o Exhibit 45: Data Table on Other respiratory diseases - Market size and forecast 2021-2026 ($ billion)
o Exhibit 46: Chart on Other respiratory diseases - Year-over-year growth 2021-2026 (%)
o Exhibit 47: Data Table on Other respiratory diseases - Year-over-year growth 2021-2026 (%)
o 5.8 Market opportunity by Type
o Exhibit 48: Market opportunity by Type ($ billion)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 49: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 50: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 51: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 52: Chart on Geographic comparison
o Exhibit 53: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 54: Chart on North America - Market size and forecast 2021-2026 ($ billion)
o Exhibit 55: Data Table on North America - Market size and forecast 2021-2026 ($ billion)
o Exhibit 56: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 58: Chart on Europe - Market size and forecast 2021-2026 ($ billion)
o Exhibit 59: Data Table on Europe - Market size and forecast 2021-2026 ($ billion)
o Exhibit 60: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 62: Chart on Asia - Market size and forecast 2021-2026 ($ billion)
o Exhibit 63: Data Table on Asia - Market size and forecast 2021-2026 ($ billion)
o Exhibit 64: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 66: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
o Exhibit 67: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
o Exhibit 68: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 70: Chart on US - Market size and forecast 2021-2026 ($ billion)
o Exhibit 71: Data Table on US - Market size and forecast 2021-2026 ($ billion)
o Exhibit 72: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Germany - Market size and forecast 2021-2026
o Exhibit 74: Chart on Germany - Market size and forecast 2021-2026 ($ billion)
o Exhibit 75: Data Table on Germany - Market size and forecast 2021-2026 ($ billion)
o Exhibit 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.9 UK - Market size and forecast 2021-2026
o Exhibit 78: Chart on UK - Market size and forecast 2021-2026 ($ billion)
o Exhibit 79: Data Table on UK - Market size and forecast 2021-2026 ($ billion)
o Exhibit 80: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.10 China - Market size and forecast 2021-2026
o Exhibit 82: Chart on China - Market size and forecast 2021-2026 ($ billion)
o Exhibit 83: Data Table on China - Market size and forecast 2021-2026 ($ billion)
o Exhibit 84: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 85: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.11 Canada - Market size and forecast 2021-2026
o Exhibit 86: Chart on Canada - Market size and forecast 2021-2026 ($ billion)
o Exhibit 87: Data Table on Canada - Market size and forecast 2021-2026 ($ billion)
o Exhibit 88: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 89: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 90: Market opportunity By Geographical Landscape ($ billion)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 91: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 92: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 93: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 94: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 95: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 96: Matrix on vendor position and classification
o 10.3 Abbott Laboratories
o Exhibit 97: Abbott Laboratories - Overview
o Exhibit 98: Abbott Laboratories - Business segments
o Exhibit 99: Abbott Laboratories - Key news
o Exhibit 100: Abbott Laboratories - Key offerings
o Exhibit 101: Abbott Laboratories - Segment focus
o 10.4 AstraZeneca Plc
o Exhibit 102: AstraZeneca Plc - Overview
o Exhibit 103: AstraZeneca Plc - Product / Service
o Exhibit 104: AstraZeneca Plc - Key news
o Exhibit 105: AstraZeneca Plc - Key offerings
o 10.5 Boehringer Ingelheim International GmbH
o Exhibit 106: Boehringer Ingelheim International GmbH - Overview
o Exhibit 107: Boehringer Ingelheim International GmbH - Business segments
o Exhibit 108: Boehringer Ingelheim International GmbH - Key news
o Exhibit 109: Boehringer Ingelheim International GmbH - Key offerings
o Exhibit 110: Boehringer Ingelheim International GmbH - Segment focus
o 10.6 Celon Pharma SA
o Exhibit 111: Celon Pharma SA - Overview
o Exhibit 112: Celon Pharma SA - Business segments
o Exhibit 113: Celon Pharma SA - Key offerings
o Exhibit 114: Celon Pharma SA - Segment focus
o 10.7 F. Hoffmann La Roche Ltd.
o Exhibit 115: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 116: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 117: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 118: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 119: F. Hoffmann La Roche Ltd. - Segment focus
o 10.8 GlaxoSmithKline Plc
o Exhibit 120: GlaxoSmithKline Plc - Overview
o Exhibit 121: GlaxoSmithKline Plc - Business segments
o Exhibit 122: GlaxoSmithKline Plc - Key news
o Exhibit 123: GlaxoSmithKline Plc - Key offerings
o Exhibit 124: GlaxoSmithKline Plc - Segment focus
o 10.9 Glenmark Pharmaceuticals Ltd.
o Exhibit 125: Glenmark Pharmaceuticals Ltd. - Overview
o Exhibit 126: Glenmark Pharmaceuticals Ltd. - Product / Service
o Exhibit 127: Glenmark Pharmaceuticals Ltd. - Key offerings
o 10.10 Novartis AG
o Exhibit 128: Novartis AG - Overview
o Exhibit 129: Novartis AG - Business segments
o Exhibit 130: Novartis AG - Key offerings
o Exhibit 131: Novartis AG - Segment focus
o 10.11 Teva Pharmaceutical Industries Ltd.
o Exhibit 132: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 133: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 134: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 135: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 136: Teva Pharmaceutical Industries Ltd. - Segment focus
o 10.12 Vertex Pharmaceuticals Inc.
o Exhibit 137: Vertex Pharmaceuticals Inc. - Overview
o Exhibit 138: Vertex Pharmaceuticals Inc. - Product / Service
o Exhibit 139: Vertex Pharmaceuticals Inc. - Key offerings
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 140: Inclusions checklist
o Exhibit 141: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 142: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 143: Research methodology
o Exhibit 144: Validation techniques employed for market sizing
o Exhibit 145: Information sources
o 11.5 List of abbreviations
o Exhibit 146: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ billion)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ billion)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Type - Market share 2021-2026 (%)
Exhibits25: Data Table on Type - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Type
Exhibits27: Data Table on Comparison by Type
Exhibits28: Chart on Asthma - Market size and forecast 2021-2026 ($ billion)
Exhibits29: Data Table on Asthma - Market size and forecast 2021-2026 ($ billion)
Exhibits30: Chart on Asthma - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Asthma - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on COPD - Market size and forecast 2021-2026 ($ billion)
Exhibits33: Data Table on COPD - Market size and forecast 2021-2026 ($ billion)
Exhibits34: Chart on COPD - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on COPD - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Allergic rhinitis - Market size and forecast 2021-2026 ($ billion)
Exhibits37: Data Table on Allergic rhinitis - Market size and forecast 2021-2026 ($ billion)
Exhibits38: Chart on Allergic rhinitis - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Allergic rhinitis - Year-over-year growth 2021-2026 (%)
Exhibits40: Chart on Cystic fibrosis - Market size and forecast 2021-2026 ($ billion)
Exhibits41: Data Table on Cystic fibrosis - Market size and forecast 2021-2026 ($ billion)
Exhibits42: Chart on Cystic fibrosis - Year-over-year growth 2021-2026 (%)
Exhibits43: Data Table on Cystic fibrosis - Year-over-year growth 2021-2026 (%)
Exhibits44: Chart on Other respiratory diseases - Market size and forecast 2021-2026 ($ billion)
Exhibits45: Data Table on Other respiratory diseases - Market size and forecast 2021-2026 ($ billion)
Exhibits46: Chart on Other respiratory diseases - Year-over-year growth 2021-2026 (%)
Exhibits47: Data Table on Other respiratory diseases - Year-over-year growth 2021-2026 (%)
Exhibits48: Market opportunity by Type ($ billion)
Exhibits49: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits50: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits51: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits52: Chart on Geographic comparison
Exhibits53: Data Table on Geographic comparison
Exhibits54: Chart on North America - Market size and forecast 2021-2026 ($ billion)
Exhibits55: Data Table on North America - Market size and forecast 2021-2026 ($ billion)
Exhibits56: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Europe - Market size and forecast 2021-2026 ($ billion)
Exhibits59: Data Table on Europe - Market size and forecast 2021-2026 ($ billion)
Exhibits60: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Asia - Market size and forecast 2021-2026 ($ billion)
Exhibits63: Data Table on Asia - Market size and forecast 2021-2026 ($ billion)
Exhibits64: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
Exhibits67: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
Exhibits68: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on US - Market size and forecast 2021-2026 ($ billion)
Exhibits71: Data Table on US - Market size and forecast 2021-2026 ($ billion)
Exhibits72: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Germany - Market size and forecast 2021-2026 ($ billion)
Exhibits75: Data Table on Germany - Market size and forecast 2021-2026 ($ billion)
Exhibits76: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on UK - Market size and forecast 2021-2026 ($ billion)
Exhibits79: Data Table on UK - Market size and forecast 2021-2026 ($ billion)
Exhibits80: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits82: Chart on China - Market size and forecast 2021-2026 ($ billion)
Exhibits83: Data Table on China - Market size and forecast 2021-2026 ($ billion)
Exhibits84: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits85: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits86: Chart on Canada - Market size and forecast 2021-2026 ($ billion)
Exhibits87: Data Table on Canada - Market size and forecast 2021-2026 ($ billion)
Exhibits88: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits89: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits90: Market opportunity By Geographical Landscape ($ billion)
Exhibits91: Impact of drivers and challenges in 2021 and 2026
Exhibits92: Overview on Criticality of inputs and Factors of differentiation
Exhibits93: Overview on factors of disruption
Exhibits94: Impact of key risks on business
Exhibits95: Vendors covered
Exhibits96: Matrix on vendor position and classification
Exhibits97: Abbott Laboratories - Overview
Exhibits98: Abbott Laboratories - Business segments
Exhibits99: Abbott Laboratories - Key news
Exhibits100: Abbott Laboratories - Key offerings
Exhibits101: Abbott Laboratories - Segment focus
Exhibits102: AstraZeneca Plc - Overview
Exhibits103: AstraZeneca Plc - Product / Service
Exhibits104: AstraZeneca Plc - Key news
Exhibits105: AstraZeneca Plc - Key offerings
Exhibits106: Boehringer Ingelheim International GmbH - Overview
Exhibits107: Boehringer Ingelheim International GmbH - Business segments
Exhibits108: Boehringer Ingelheim International GmbH - Key news
Exhibits109: Boehringer Ingelheim International GmbH - Key offerings
Exhibits110: Boehringer Ingelheim International GmbH - Segment focus
Exhibits111: Celon Pharma SA - Overview
Exhibits112: Celon Pharma SA - Business segments
Exhibits113: Celon Pharma SA - Key offerings
Exhibits114: Celon Pharma SA - Segment focus
Exhibits115: F. Hoffmann La Roche Ltd. - Overview
Exhibits116: F. Hoffmann La Roche Ltd. - Business segments
Exhibits117: F. Hoffmann La Roche Ltd. - Key news
Exhibits118: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits119: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits120: GlaxoSmithKline Plc - Overview
Exhibits121: GlaxoSmithKline Plc - Business segments
Exhibits122: GlaxoSmithKline Plc - Key news
Exhibits123: GlaxoSmithKline Plc - Key offerings
Exhibits124: GlaxoSmithKline Plc - Segment focus
Exhibits125: Glenmark Pharmaceuticals Ltd. - Overview
Exhibits126: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibits127: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibits128: Novartis AG - Overview
Exhibits129: Novartis AG - Business segments
Exhibits130: Novartis AG - Key offerings
Exhibits131: Novartis AG - Segment focus
Exhibits132: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits133: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits134: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits135: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits136: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits137: Vertex Pharmaceuticals Inc. - Overview
Exhibits138: Vertex Pharmaceuticals Inc. - Product / Service
Exhibits139: Vertex Pharmaceuticals Inc. - Key offerings
Exhibits140: Inclusions checklist
Exhibits141: Exclusions checklist
Exhibits142: Currency conversion rates for US$
Exhibits143: Research methodology
Exhibits144: Validation techniques employed for market sizing
Exhibits145: Information sources
Exhibits146: List of abbreviations